Company intelligence / Profile preview

BeyondStyle

Gangnam-gu, Seoul, South Korea

Ownership: Private
Development stage: Other

Overview

BeyondStyle is a South Korean biotechnology company specializing in the development of exosome-based products for regenerative medicine and medical aesthetics. The company utilizes a proprietary platform for the isolation and stabilization of high-purity exosomes derived from stem cells and other biological sources. Their flagship product line, EXOXE, targets skin rejuvenation and hair loss by delivering bioactive molecules directly to target cells. BeyondStyle is currently expanding its research into therapeutic applications for inflammatory diseases and tissue repair. The company aims to lead the global market in exosome-based cosmeceuticals and biopharmaceuticals.

Therapeutic areas: ImmunologyDermatology
Modalities: Exosome-based therapyBiologic
Industry: Biotech

Beyond the preview

Go deeper on BeyondStyle.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on BeyondStyle.

Explore the full profile